Pancreatic exocrine insufficiency (PEI) secondary to chronic use of long-acting (LA) somatostatin analogues (SSA) in pts with neuroendocrine tumors (NETs): Pooled analysis (USA and UK).
Sign Up to like & getrecommendations! Published in 2018 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2018.36.15_suppl.e16166
Abstract: e16166Background: SSAs are the most common treatment for well-differentiated NETs. Side effects include biliary and GI disorders, injection-site pain and hyperglycemia. There is often misdiagnosis ... read more here.
Keywords: chronic use; insufficiency pei; secondary chronic; pancreatic exocrine ... See more keywords